Trial Profile
A phase II trial of ALS L1023 in obese patients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Feb 2012
Price :
$35
*
At a glance
- Drugs ALS L1023 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors AngioLab Inc
- 16 Feb 2012 New trial record